In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Midatech Pharma PLC

Latest From Midatech Pharma PLC

New CEO of Renamed Spin-Out Fortovia Therapeutics Will Be ‘Solely US-Focused’

Newly installed Fortovia Therapeutics CEO Peter Melnyk tells Scrip his arrival and the company’s name change from Midatech Pharma US signals a strategic revamp for the privately held spin-out.

Commercial Companies

Deal Watch: Celgene Joins Line Of Partners Tapping Exscientia’s AI-Driven Discovery Engine

While the proposed Bristol/Celgene merger nears an April vote, Celgene continues a recent spate of deal-making, paying $25m up front to Exscientia to discover small molecule candidates for cancer and autoimmune disease.

Business Strategies Commercial

Embattled Midatech Receives Lifeline From China To Save Cancer Candidate

A Chinese billionaire has invested in UK biotech Midatech and signed a licensing deal for an as yet unapproved carcinoid cancer drug, sending it much-needed backing just days after the company said it did not have enough cash to get it to the second half of the year.

Cancer Financing

UK's Midatech Makes Desperate Cash Call

The Oxford-based biotech needs more money and fast to fund development of MTD201, which it believes offers a number of competitive advantages over Novartis blockbuster Sandostatin LAR.

Financing Cancer
See All

Company Information

  • Industry
  • Biotechnology
  • Distributors
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Site Specific
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Other Names / Subsidiaries
    • DARA BioSciences, Inc.
    • MidaSol Therapeutics LP
    • Midatech Group Ltd.
    • Oncogenerix, Inc.
    • Pharmida AG
    • Point Therapeutics, Inc.